2 results
Approved WMOCompleted
This study is being conducted to determine the safety and efficacy of the study drug BIVV001 when used as a once-a-week prophylaxis treatment or as an on-demand (as-needed) treatment for bleeding in patients 12 years and older with severe hemophilia…
Approved WMORecruiting
To investigate whether on demand dosing using population-based PK-models in VWD patients is reliable and feasible.